| Anonymous | |
|---|---|
| Log in for more site access. | |
![]() | |
CMAH (cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminate monooxygenase) pseudogene)
Sialic acids are sugars typically found at the outer terminal position of glycan chains that cover the surface of all vertebrate cells. The most commonly-expressed sialic acid is N-acetylneuraminic acid (Neu5Ac), which is the precursor for N-glycolylneuraminic acid (Neu5Gc) synthesis - a conversion mediated by action of the CMP-N-acetylneuraminic acid hydroxylase (CMAH) enzyme. While both Neu5Ac and Neu5Gc are found to be expressed in many mammals (including our closest evolutionary cousins, the great apes), the single-copy human CMAH gene was pseudogenized by an Alu-mediated deletion event, which seems to have occurred ~2-3 million years ago in our ancestors, and is now universal to the human population. This genetic loss has multiple consequences that are still being investigated, ranging from pathogen susceptibility to changes in the immune system.
Chou, H.H., Hayakawa, T., Diaz, S., Krings, M., Indriati, E., Leakey, M., Paabo, S., Satta, Y., Takahata, N., and Varki, A. 2002. Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution. Proc Natl Acad Sci U S A. 99:11736-11741.
Hayakawa, T., Aki, I., Varki, A., Satta, Y., and Takahata, N. 2006. Fixation of the Human-Specific CMP-N-Acetylneuraminic Acid Hydroxylase Pseudogene and Implications of Haplotype Diversity for Human Evolution. Genetics. 172:1139-1146.
Hedlund, M., Tangvoranuntakul, P., Takematsu, H., Long, J.M., Housley, G.D., Kozutsumi, Y., Suzuki, A., Wynshaw-Boris, A., Ryan, A.F., Gallo, R.L., Varki, N., and Varki, A. 2007. N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol Cell Biol. 27:4340-4346.
Varki, A. 2009. Multiple changes in sialic acid biology during human evolution. Glycoconj J. 26:231-245.

